Allarity Therapeutics, Inc. Fair Value Adjustment of Warrants
Allarity Therapeutics, Inc. (ALLR) reported Fair Value Adjustment of Warrants of -$2.66 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-08-05
- Allarity Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-12-31 was $2.17M.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-09-30 was $4.19M.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-06-30 was -$2.25M, a 382.06% decline year-over-year.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-03-31 was $65.00, a 97.13% decline year-over-year.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was $4.19M.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for fiscal 2021 was $474.00K, a 17.28% decline from fiscal 2020.
- Allarity Therapeutics, Inc. fair value adjustment of warrants for fiscal 2020 was $573.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -$2.66M 10-Q · filed 2024-08-05 | ||||
| 2023-12-31 | $2.17M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-08 | $6.36M derived: sum of 2 quarters · filed 2024-03-08 | $4.11M derived: sum of 3 quarters · filed 2024-08-05 | $4.19M 10-K · filed 2024-03-08 | |
| 2023-09-30 | $4.19M 10-Q · filed 2023-11-14 | $1.94M derived: sum of 2 quarters · filed 2024-08-05 | $2.02M 10-K · filed 2024-03-08 | $4.19M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$2.25M 10-Q · filed 2024-08-05 | |||
| 2023-03-31 | $65.00 10-Q · filed 2023-05-11 | ||||
| 2022-06-30 | $797.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $800.00K 10-Q · filed 2023-08-14 | $800.00K derived: sum of 3 quarters · filed 2023-08-14 | $800.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $2.27K 10-Q · filed 2023-05-11 | $2.27K derived: sum of 2 quarters · filed 2023-05-11 | $2.27K derived: sum of 3 quarters · filed 2023-05-11 | $275.26K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $273.00K derived: sum of 3 quarters · filed 2023-03-13 | $474.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $273.00K derived: sum of 2 quarters · filed 2022-11-14 | $474.00K 10-Q · filed 2022-11-14 | $298.00K 10-Q · filed 2021-11-23 | $494.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $474.00K 10-Q · filed 2022-10-07 | $494.00K derived: sum of 3 quarters · filed 2022-10-07 | ||
| 2021-03-31 | $201.00K 10-Q · filed 2022-05-27 | $221.00K derived: sum of 2 quarters · filed 2022-05-27 | |||
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | $573.00K 10-K · filed 2022-05-17 | |||
| 2020-09-30 | $553.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |